This report provides understanding and access to the breast cancer partnering deals and agreements entered into by the worlds leading healthcare companies.Trends in breast cancer partnering dealsTop breast cancer deals by valu...
|
$ 1695
|
|
|
Report SummaryGlobalData, the industry analysis specialist, has released its new report, Breast Cancer - Global Drug Forecasts and Treatment Analysis to 2020”. The report is an essential source of informat...
|
$ 6995
|
|
|
In 2010, almost 50% of breast cancer sales were due to three branded targeted therapies. With a large unmet clinical need, further agents are req...
|
$ 3145
|
|
|
GlobalData, the industry analysis specialist, has released its new report, ”. The rep...
|
$ 2000
|
|
|
AN EXCEPTIONALLY COST EFFECTIVE SERVICE INCLUDING FORMATS TO MEET EVERY INFORMATION NEEDEspi...
|
$ 2615
|
|
|
GlobalData, the industry analysis specialist’s new report, Breast Cancer – Drug Pipeline Analysis and Market Forecasts to 2016”...
|
$ 2000
|
|
|